• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

广泛耐药结核病的危险因素:综述

Risk factors for extensively drug-resistant tuberculosis: a review.

作者信息

Flor de Lima Bárbara, Tavares Margarida

机构信息

Master Programme in Medicine, Hospital de São João and University of Porto Medical School, Portugal.

出版信息

Clin Respir J. 2014 Jan;8(1):11-23. doi: 10.1111/crj.12044. Epub 2013 Oct 1.

DOI:10.1111/crj.12044
PMID:23875862
Abstract

INTRODUCTION

Extensively drug-resistant tuberculosis (XDR-TB) is emerging as a global public health problem. Its treatment is more expensive and difficult, and the outcomes much severe. The identification of risk factors for XDR-TB is of paramount importance to design effective TB control strategies.

OBJECTIVE

To review published articles on risk factors for XDR-TB.

METHODS

We identified 249 English articles on PubMed, and 182 were excluded by the abstract. The remaining articles were retrieved for full-text detailed evaluation by authors, and 27 relevant articles were selected for final review.

RESULTS

Some risk factors were consistently present, mainly previous TB treatment and its length. Other conditions often associated were immigration, alcoholism and HIV coinfection. Pre-XDR-TB points to an increased risk of XDR-TB.

CONCLUSION

The information regarding determinants of XDR-TB is relatively weak. However, special emphasis should be given to minimize the risks of TB retreatment to prevent the emergence of highly resistant TB.

摘要

引言

广泛耐药结核病(XDR-TB)正成为一个全球公共卫生问题。其治疗成本更高且难度更大,后果也更为严重。确定XDR-TB的危险因素对于设计有效的结核病控制策略至关重要。

目的

综述已发表的关于XDR-TB危险因素的文章。

方法

我们在PubMed上检索到249篇英文文章,通过摘要排除了182篇。其余文章由作者检索全文进行详细评估,最终选取27篇相关文章进行综述。

结果

一些危险因素始终存在,主要是既往结核病治疗及其疗程。其他常相关的情况有移民、酗酒和HIV合并感染。广泛耐药前结核病提示XDR-TB风险增加。

结论

关于XDR-TB决定因素的信息相对较少。然而,应特别强调尽量降低结核病复治的风险,以预防高度耐药结核病的出现。

相似文献

1
Risk factors for extensively drug-resistant tuberculosis: a review.广泛耐药结核病的危险因素:综述
Clin Respir J. 2014 Jan;8(1):11-23. doi: 10.1111/crj.12044. Epub 2013 Oct 1.
2
Multidrug-resistant and extensively drug-resistant tuberculosis: implications for the HIV epidemic and antiretroviral therapy rollout in South Africa.耐多药和广泛耐药结核病:对南非艾滋病毒疫情及抗逆转录病毒治疗推广的影响
J Infect Dis. 2007 Dec 1;196 Suppl 3:S482-90. doi: 10.1086/521121.
3
Representations of MDR and XDR-TB in South African newspapers.南非报纸上耐多药结核病和广泛耐药结核病的报道。
Soc Sci Med. 2012 Jul;75(2):410-8. doi: 10.1016/j.socscimed.2012.02.039. Epub 2012 Mar 30.
4
Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.高 HIV 流行环境中耐多药和广泛耐药结核病的家庭接触者调查。
Int J Tuberc Lung Dis. 2011 Sep;15(9):1170-5, i. doi: 10.5588/ijtld.10.0781.
5
A historical review of XDR tuberculosis in the Western Cape province of South Africa.南非西开普省广泛耐药结核病的历史回顾。
S Afr Med J. 2011 Sep 5;101(9):636-8.
6
Provider perspectives on drug-resistant tuberculosis and human immunodeficiency virus care in South Africa: a qualitative case study.南非医疗服务提供者对耐多药结核病和人类免疫缺陷病毒护理的看法:一项定性案例研究。
Int J Tuberc Lung Dis. 2016 Nov;20(11):1483-1488. doi: 10.5588/ijtld.16.0111.
7
Genotypic diversity of extensively drug-resistant tuberculosis (XDR-TB) in South Africa.南非广泛耐药结核病(XDR-TB)的基因型多样性
Int J Tuberc Lung Dis. 2008 Jan;12(1):99-104.
8
Clinical and operational value of the extensively drug-resistant tuberculosis definition.广泛耐药结核病定义的临床及操作价值
Eur Respir J. 2007 Oct;30(4):623-6. doi: 10.1183/09031936.00077307. Epub 2007 Aug 9.
9
Extensively drug-resistant tuberculosis: new strains, new challenges.广泛耐药结核病:新菌株,新挑战。
Expert Rev Anti Infect Ther. 2008 Oct;6(5):713-24. doi: 10.1586/14787210.6.5.713.
10
[MDR, pre-XDR and XDR drug-resistant tuberculosis in Poland in 2000-2009].[2000 - 2009年波兰的耐多药、广泛耐药前和广泛耐药结核病]
Pneumonol Alergol Pol. 2011;79(4):278-87.

引用本文的文献

1
Advances and prospects for treatment strategies of drug-resistant tuberculosis: a review.耐多药结核病治疗策略的进展与展望:综述
GMS Hyg Infect Control. 2025 Jun 26;20:Doc33. doi: 10.3205/dgkh000562. eCollection 2025.
2
Second-line drug-resistant TB and associated risk factors in Karakalpakstan, Uzbekistan.乌兹别克斯坦卡拉卡尔帕克斯坦的耐多药结核病及相关危险因素
IJTLD Open. 2024 Sep 1;1(9):391-397. doi: 10.5588/ijtldopen.24.0351. eCollection 2024 Sep.
3
Bacteriophages of Mycobacterium tuberculosis, their diversity, and potential therapeutic uses: a review.
结核分枝杆菌噬菌体及其多样性和潜在的治疗用途:综述。
BMC Infect Dis. 2022 Dec 22;22(1):957. doi: 10.1186/s12879-022-07944-9.
4
Risk Factors for Poor Outcomes Among Patients with Extensively Drug-Resistant Tuberculosis (XDR-TB): A Scoping Review.广泛耐药结核病(XDR-TB)患者预后不良的危险因素:一项范围综述
Infect Drug Resist. 2021 Dec 16;14:5429-5448. doi: 10.2147/IDR.S339972. eCollection 2021.
5
Risk factors for drug-resistant tuberculosis, the association between comorbidity status and drug-resistant patterns: a retrospective study of previously treated pulmonary tuberculosis in Shandong, China, during 2004-2019.耐药结核病的危险因素、合并症状况与耐药模式之间的关系:中国山东 2004-2019 年既往治疗肺结核的回顾性研究。
BMJ Open. 2021 Jun 16;11(6):e044349. doi: 10.1136/bmjopen-2020-044349.
6
[Epidemiological profile of extensively drug-resistant tuberculosis in Peru, 2013-2015Perfil epidemiológico da tuberculose extremamente resistente no Peru, 2013-2015].[2013 - 2015年秘鲁广泛耐药结核病的流行病学概况 2013 - 2015年秘鲁耐多药结核病的流行病学概况]
Rev Panam Salud Publica. 2020 Sep 23;44:e29. doi: 10.26633/RPSP.2020.29. eCollection 2020.
7
Multi- and extensively drug-resistant tuberculosis in Latvia: trends, characteristics and treatment outcomes.拉脱维亚的多重耐药和广泛耐药结核病:趋势、特征及治疗结果
Public Health Action. 2014 Oct 21;4(Suppl 2):S47-53. doi: 10.5588/pha.14.0041.
8
Does Alcohol consumption during multidrug-resistant tuberculosis treatment affect outcome?. A population-based study in Kerala, India.耐多药结核病治疗期间饮酒是否会影响治疗结果?印度喀拉拉邦的一项基于人群的研究。
Ann Am Thorac Soc. 2014 Jun;11(5):712-8. doi: 10.1513/AnnalsATS.201312-447OC.